drugset / Trial / NCT07855991
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Sonrotoclax in Participants With Severe Hepatic Impairment
Non-randomizedParallel-groupOpen-labelOther
Summary
The goal of this study is to understand how the body processes sonrotoclax in adults with serious liver problems compared to adults with normal liver function.
Timeline
- Start
- 2026-10-15
- Primary completion
- 2027-02-08
- Completion
- 2027-02-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sonrotoclax | Other / unclassified | — | Oral |
Indications
No indication recorded.